Food News and Research

RSS

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty, according to a new Mayo Clinic study. The study was undertaken as a quality control initiative to reduce the potential radiation risks of cancer to patients and PCI operators.

16 Mar 2010

Hi-maize whole grain corn flour and Hi-maize resistant starch increase satiety

A University of Toronto (Toronto, Canada) research team, led by G. Harvey Anderson, Ph.D., just published results of a new study in the American Journal of Clinical Nutrition, showing that the quantity of resistant starch in foods correlates with blood glucose response and reduced food intake after two hours.

16 Mar 2010

New research initiative launched to accelerate development of improved crops

A new research initiative has been launched to accelerate the development of improved crops with higher yields and consistent, high quality products. The £6M Crop Improvement Research Club is led by the Biotechnology and Biological Sciences Research Council, the UK's largest public funder of agri-food research and includes the Scottish Government and 13 companies representing plant breeders, farmers and food processors.

16 Mar 2010

FDA approves Irvine Scientific's Vit Kit-Freeze and Vit Kit-Thaw for cryopreservation of all stages of embryos

Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.

16 Mar 2010

Tips for reducing LDL cholesterol

Cardiovascular disease is the No.1 killer in North America. And high cholesterol is one of the primary risk factors of coronary heart disease and stroke. According to the Heart and Stroke Foundation, almost 40% of Canadian adults are classified as having high blood cholesterol levels.

16 Mar 2010

New comprehensive trademark search capabilities available for pharmaceutical industry

CT Corsearch, part of CT, a Wolters Kluwer business and the premier provider of clearance and protection solutions for trademark and brand professionals, today announced the availability of its new comprehensive trademark search capabilities designed specifically for the specialized needs of the pharmaceutical industry.

16 Mar 2010

New cerebral protection device prevents stroke during treatment to clear blocked carotid arteries

An important interventional radiology advancement-the use of a new cerebral protection device in combination with FDA-approved carotid stents in high-surgical-risk patients-provides a minimally invasive, safe and effective way to prevent stroke from occurring during treatment to clear blocked carotid arteries, according to research released at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

16 Mar 2010

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research.

16 Mar 2010

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Physicians and nutrition scientists from around the world gathered today in Orlando for the opening of the Global Nutrition Transition Conference in order to discuss emerging trends and grass roots solutions to the global obesity epidemic employing balanced nutrition and teaching healthy active lifestyles.

16 Mar 2010

Hitachi, NextDocs form partnership in document management solutions for pharmaceutical manufacturers

Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.

16 Mar 2010

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

There's a new interventional radiology tool showing promise in the treatment of uterine fibroids: magnetic resonance-guided focused ultrasound (MRgFUS), a minimally invasive treatment that uses high-energy ultrasound waves to generate heat at a specific point to destroy uterine fibroid tissue and relieve symptoms.

16 Mar 2010

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Boston Scientific Corporation today announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2™ Paclitaxel-Eluting Stent System or the Express® bare-metal stent.

16 Mar 2010

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

In a Washington Post opinion piece, Desmond Tutu, archbishop emeritus of Cape Town, South Africa, and Nobel Peace Prize recipient, speaks out against efforts to deny individuals "their fundamental rights and freedoms" based on their sexual orientation.

16 Mar 2010

Mental health experts cite positive aspects of March Madness, offer tips to temper drawbacks

The perfect storm of sporting events is nigh, and for three weeks people will become riveted by the David and Goliath matchups and Cinderella stories set against a backdrop of beers and big screens and bar food favorites.

16 Mar 2010

Clinical evaluation of benzodiazepine products is now allowed using Acura's Aversion Technology

Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.

16 Mar 2010

U.N. Secretary-General visits Haiti to monitor international aid response

During his second visit to Haiti since the January earthquake, U.N. Secretary-General Ban Ki-moon "promised Haitians on Sunday that the world has not forgotten the quake-torn nation as it suffers from a shortage of shelter and growing violence in teeming camps for the homeless," the Associated Press reports (Katz, 3/14).

16 Mar 2010

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

16 Mar 2010

FDA approves Watson Pharmaceuticals' ANDA for generic Cardizem LA

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.

16 Mar 2010

Lilly receives exclusive rights to commercialize Acrux's testosterone solution

Eli Lilly and Company and Acrux announced today that they have entered into an exclusive worldwide license agreement for the potential commercialization of Acrux's experimental underarm testosterone solution (proposed tradename AXIRON™).

16 Mar 2010

Impax Laboratories initiates challenge of patent over generic TRILIPIX

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patent listed by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in connection with its TRILIPIX® (choline fenofibrate) delayed-release capsules, 135 mg and 45 mg.

15 Mar 2010

Food News and Research

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Hi-maize whole grain corn flour and Hi-maize resistant starch increase satiety

New research initiative launched to accelerate development of improved crops

FDA approves Irvine Scientific's Vit Kit-Freeze and Vit Kit-Thaw for cryopreservation of all stages of embryos

Tips for reducing LDL cholesterol

New comprehensive trademark search capabilities available for pharmaceutical industry

New cerebral protection device prevents stroke during treatment to clear blocked carotid arteries

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Hitachi, NextDocs form partnership in document management solutions for pharmaceutical manufacturers

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Opinions: Discrimination against sexual orientation; WFP in Somalia; Haiti's recovery; WHO's policy role

Mental health experts cite positive aspects of March Madness, offer tips to temper drawbacks

Clinical evaluation of benzodiazepine products is now allowed using Acura's Aversion Technology

U.N. Secretary-General visits Haiti to monitor international aid response

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

FDA approves Watson Pharmaceuticals' ANDA for generic Cardizem LA

Lilly receives exclusive rights to commercialize Acrux's testosterone solution

Impax Laboratories initiates challenge of patent over generic TRILIPIX

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News